David C Venables
Food and Nutrition
Synpromics
Ukraine
Biography
David have worked in a variety of technical and business roles in the biotech industry over the last 25 years. I was previously founding CEO of Anatara Therapeutics (a life sciences company I managed through private fund raising and IPO in Australia); CEO of Ark Therapeutics with responsibility for leading the company through a transition to a viral contract development and manufacturing service model and ultimately a sale of the business assets; an advisor to Syncona Partners and VP – CMC for NightstaRx, an ophthalmology focused gene therapy company formed by Syncona. Previously at Intercell, I was responsible for building Intercell’s manufacturing capabilities in Europe and the USA. As Site Head for vaccine manufacturing operations in the UK I was responsible for the European and US licensure, pre-approval inspection and commercial supply of Ixiaro®, a Japanese Encephalitis vaccine, followed as Chief Operating Officer of Intercell USA Inc. based in Maryland, USA. Before joining Intercell I was Director of Operations at BioReliance Europe.
Research Interest
David have worked in a variety of technical and business roles in the biotech industry over the last 25 years. I was previously founding CEO of Anatara Therapeutics (a life sciences company I managed through private fund raising and IPO in Australia); CEO of Ark Therapeutics with responsibility for leading the company through a transition to a viral contract development and manufacturing service model and ultimately a sale of the business assets; an advisor to Syncona Partners and VP – CMC for NightstaRx, an ophthalmology focused gene therapy company formed by Syncona. Previously at Intercell, I was responsible for building Intercell’s manufacturing capabilities in Europe and the USA. As Site Head for vaccine manufacturing operations in the UK I was responsible for the European and US licensure, pre-approval inspection and commercial supply of Ixiaro®, a Japanese Encephalitis vaccine, followed as Chief Operating Officer of Intercell USA Inc. based in Maryland, USA. Before joining Intercell I was Director of Operations at BioReliance Europe.
